ATE389030T1 - Wasserlösliche lumineszente quantum-dots sowie deren biokonjugate - Google Patents

Wasserlösliche lumineszente quantum-dots sowie deren biokonjugate

Info

Publication number
ATE389030T1
ATE389030T1 AT99970854T AT99970854T ATE389030T1 AT E389030 T1 ATE389030 T1 AT E389030T1 AT 99970854 T AT99970854 T AT 99970854T AT 99970854 T AT99970854 T AT 99970854T AT E389030 T1 ATE389030 T1 AT E389030T1
Authority
AT
Austria
Prior art keywords
water
luminescent quantum
bioconjugates
dots
soluble luminescent
Prior art date
Application number
AT99970854T
Other languages
English (en)
Inventor
Shuming Nie
Warren Chan
Steven Amory
Original Assignee
Univ Indiana Res & Tech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Indiana Res & Tech Corp filed Critical Univ Indiana Res & Tech Corp
Application granted granted Critical
Publication of ATE389030T1 publication Critical patent/ATE389030T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
AT99970854T 1998-09-24 1999-09-24 Wasserlösliche lumineszente quantum-dots sowie deren biokonjugate ATE389030T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10174898P 1998-09-24 1998-09-24
US13198799P 1999-04-30 1999-04-30

Publications (1)

Publication Number Publication Date
ATE389030T1 true ATE389030T1 (de) 2008-03-15

Family

ID=26798586

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99970854T ATE389030T1 (de) 1998-09-24 1999-09-24 Wasserlösliche lumineszente quantum-dots sowie deren biokonjugate

Country Status (8)

Country Link
US (2) US6468808B1 (de)
EP (1) EP1115888B1 (de)
JP (1) JP4630459B2 (de)
AT (1) ATE389030T1 (de)
AU (1) AU3468500A (de)
CA (1) CA2345376C (de)
DE (1) DE69938353T2 (de)
WO (1) WO2000029617A2 (de)

Families Citing this family (143)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933331B2 (en) * 1998-05-22 2005-08-23 Nanoproducts Corporation Nanotechnology for drug delivery, contrast agents and biomedical implants
US6576155B1 (en) * 1998-11-10 2003-06-10 Biocrystal, Ltd. Fluorescent ink compositions comprising functionalized fluorescent nanocrystals
JP2003522962A (ja) * 2000-02-16 2003-07-29 クァンタム・ドット・コーポレイション 半導体ナノクリスタルを使用するマイクロアレイ法
US20030013096A1 (en) 2000-03-16 2003-01-16 Ichiro Yamashita Nucleotide detector, process for producing the same and process for morming forming fine particle membrane
JP2004500109A (ja) * 2000-03-22 2004-01-08 クァンタム・ドット・コーポレイション ビーズベースの核酸アッセイにおける半導体ナノクリスタルの使用方法
US6759235B2 (en) 2000-04-06 2004-07-06 Quantum Dot Corporation Two-dimensional spectral imaging system
KR100995457B1 (ko) 2000-08-22 2010-11-18 프레지던트 앤드 펠로우즈 오브 하버드 칼리지 나노센서 제조 방법
US6649138B2 (en) 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
US6572784B1 (en) 2000-11-17 2003-06-03 Flex Products, Inc. Luminescent pigments and foils with color-shifting properties
US6565770B1 (en) 2000-11-17 2003-05-20 Flex Products, Inc. Color-shifting pigments and foils with luminescent coatings
KR20030055346A (ko) 2000-12-11 2003-07-02 프레지던트 앤드 펠로우즈 오브 하버드 칼리지 나노센서
US20060248982A1 (en) * 2001-02-20 2006-11-09 Nanoproducts Corp. Nanomaterials manufacturing methods and products thereof
EP1366347B8 (de) 2001-03-09 2010-02-03 Univ Reims Champagne Ardenne L Hochempfindliche nicht-isotopische wasserlöslische nanokristalle
US20030013109A1 (en) * 2001-06-21 2003-01-16 Ballinger Clinton T. Hairpin sensors using quenchable fluorescing agents
US6819845B2 (en) 2001-08-02 2004-11-16 Ultradots, Inc. Optical devices with engineered nonlinear nanocomposite materials
US6710366B1 (en) 2001-08-02 2004-03-23 Ultradots, Inc. Nanocomposite materials with engineered properties
US6794265B2 (en) 2001-08-02 2004-09-21 Ultradots, Inc. Methods of forming quantum dots of Group IV semiconductor materials
EP1436424A4 (de) * 2001-09-18 2005-11-16 Us Genomics Inc Differentielles tagging von polymeren zur hochaufgelösten linearen analyse
WO2003034031A2 (en) * 2001-10-15 2003-04-24 Mount Sinai School Of Medicine Of New York University Highly sensitive methods for protein detection in proteomics
GB2381530A (en) * 2001-11-01 2003-05-07 Oxonica Ltd Water-soluble particles of luminescent materials and their use in Biotagging
DE10153829A1 (de) 2001-11-05 2003-05-28 Bayer Ag Assay basierend auf dotierten Nanoteilchen
AU2002362013B2 (en) 2001-11-21 2008-04-24 Applied Biosystems, Llc. Digital assay
JP3897285B2 (ja) * 2002-02-05 2007-03-22 日立ソフトウエアエンジニアリング株式会社 生体高分子検出用試薬及び生体高分子検出方法
WO2003091455A1 (en) * 2002-04-23 2003-11-06 U.S.Genomics, Inc. Compositions and methods related to two-arm nucleic acid probes
US7998923B2 (en) * 2002-05-07 2011-08-16 The Regents Of The University Of California Bioactivation of particles
EP1506390B1 (de) 2002-05-17 2011-12-14 Life Technologies Corporation Vorrichtung und verfahren zur unterscheidung mehrerer fluoreszenzsignale anhand ihrer anregungswellenlänge
JP2005526254A (ja) 2002-05-17 2005-09-02 アプレラ コーポレイション 励起光源を備える光学機器
WO2003100101A1 (en) * 2002-05-28 2003-12-04 U.S. Genomics, Inc. Methods and apparati using single polymer analysis
JP2005533256A (ja) * 2002-07-17 2005-11-04 ユー．エス． ジェノミクス， インコーポレイテッド キメラタグを用いるポリマーを分析するための方法と組成物
US7563507B2 (en) * 2002-08-16 2009-07-21 University Of Massachusetts Pyridine and related ligand compounds, functionalized nanoparticulate composites and methods of preparation
US7361821B2 (en) 2002-09-20 2008-04-22 Intel Corporation Controlled alignment of nanobarcodes encoding specific information for scanning probe microscopy (SPM) reading
WO2004038037A2 (en) 2002-09-20 2004-05-06 Intel Corporation Controlled alignment of nano-barcodes encoding specific information for scanning probe microscopy (spm) reading
US7708974B2 (en) 2002-12-10 2010-05-04 Ppg Industries Ohio, Inc. Tungsten comprising nanomaterials and related nanotechnology
US20050129580A1 (en) * 2003-02-26 2005-06-16 Swinehart Philip R. Microfluidic chemical reactor for the manufacture of chemically-produced nanoparticles
JP4491417B2 (ja) * 2003-08-04 2010-06-30 エモリー・ユニバーシティ ナノ化学種が埋め込まれた多孔質材料、その製造方法、およびその使用方法
JP4418220B2 (ja) * 2003-09-09 2010-02-17 日立ソフトウエアエンジニアリング株式会社 耐久性に優れたナノ粒子及びその製造方法
US20050074779A1 (en) * 2003-10-02 2005-04-07 Tuan Vo-Dinh SERS molecular probe for diagnostics and therapy
WO2005053649A1 (en) * 2003-11-05 2005-06-16 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Biofunctionalized quantum dots for biological imaging
US20070275007A1 (en) * 2003-11-05 2007-11-29 The Government Of The United States Of America, Represented By The Secretary Of Health And Human S Carbohydrate Antigen-Nanoparticle Conjugates and Uses Thereof as Antimetastatic Agents in Treating Cancer
WO2005050171A2 (en) * 2003-11-17 2005-06-02 U.S. Genomics, Inc. Methods and compositions relating to single reactive center reagents
US7381529B2 (en) * 2003-12-31 2008-06-03 Intel Corporation Methods and compositions for detecting nucleic acids using scanning probe microscopy and nanocodes
US7323696B2 (en) 2004-01-09 2008-01-29 Applera Corporation Phosphor particle coded beads
US7645397B2 (en) * 2004-01-15 2010-01-12 Nanosys, Inc. Nanocrystal doped matrixes
US7374807B2 (en) * 2004-01-15 2008-05-20 Nanosys, Inc. Nanocrystal doped matrixes
FR2867180B1 (fr) 2004-03-02 2006-06-16 Univ Claude Bernard Lyon Nanoparticules hybrides comprenant un coeur de ln203 porteuses de ligands biologiques et leur procede de preparation
US20080032420A1 (en) * 2004-03-30 2008-02-07 Lambert James L Surface Enhanced Raman Scattering and Multiplexed Diagnostic Assays
US20050250141A1 (en) * 2004-03-30 2005-11-10 Lambert James L Diagnostic assays including multiplexed lateral flow immunoassays with quantum dots
WO2005102396A2 (en) 2004-04-20 2005-11-03 Emory University Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof
CA2505655C (en) * 2004-04-28 2013-07-09 Warren Chan Stable, water-soluble quantum dot, method of preparation and conjugates thereof
US7405037B2 (en) * 2004-05-07 2008-07-29 Lonza Walkersville, Inc. Methods and tools for detecting collagen degradation
WO2006083269A2 (en) * 2004-05-14 2006-08-10 Florida Atlantic University Luminescent nanosensors
US7335345B2 (en) * 2004-05-24 2008-02-26 Drexel University Synthesis of water soluble nanocrystalline quantum dots and uses thereof
EP1607737A1 (de) * 2004-06-17 2005-12-21 Patrick Hunziker Gerät und Methode zur Detektion und Messung von Nukleinsäuresträngen in Lösung
CN100395306C (zh) * 2004-06-22 2008-06-18 武汉大学 一种油溶性量子点水溶性化的方法
WO2006093516A2 (en) * 2004-06-22 2006-09-08 The Regents Of The University Of California Peptide-coated nanoparticles with graded shell compositions
US7405002B2 (en) * 2004-08-04 2008-07-29 Agency For Science, Technology And Research Coated water-soluble nanoparticles comprising semiconductor core and silica coating
US7534489B2 (en) * 2004-09-24 2009-05-19 Agency For Science, Technology And Research Coated composites of magnetic material and quantum dots
WO2006037226A1 (en) * 2004-10-05 2006-04-13 Mcgill University Use of quantum dots for biological labels and sensors
US8154002B2 (en) 2004-12-06 2012-04-10 President And Fellows Of Harvard College Nanoscale wire-based data storage
US20060217893A1 (en) * 2005-01-07 2006-09-28 Yanbin Li Method for detecting an unknown contaminant concentration in a substance
US20080135490A1 (en) * 2005-01-07 2008-06-12 Board Of Trustees Of The University Of Arkansas Quantum dot biolabeling and immunomagnetic separation for detection of contaminants
US7699979B2 (en) * 2005-01-07 2010-04-20 Board Of Trustees Of The University Of Arkansas Separation system and efficient capture of contaminants using magnetic nanoparticles
KR101088147B1 (ko) * 2005-01-17 2011-12-02 에이전시 포 사이언스, 테크놀로지 앤드 리서치 신규한 수용성 나노결정 및 그 제조방법
US20070015176A1 (en) * 2005-02-18 2007-01-18 Applera Corporation Small nucleic acid detection probes and uses thereof
US20090042032A1 (en) * 2005-05-04 2009-02-12 Agency For Science, Technology And Research Novel water-soluble nanocrystals comprising a low molecular weight coating reagent, and methods of preparing the same
US20090098663A1 (en) * 2005-05-04 2009-04-16 Agency For Science, Technology And Research Novel water-soluble nanocrystals comprising a polymeric coating reagent, and methods of preparing the same
US20100227382A1 (en) 2005-05-25 2010-09-09 President And Fellows Of Harvard College Nanoscale sensors
US9297092B2 (en) 2005-06-05 2016-03-29 Qd Vision, Inc. Compositions, optical component, system including an optical component, devices, and other products
US8845927B2 (en) 2006-06-02 2014-09-30 Qd Vision, Inc. Functionalized nanoparticles and method
WO2006132659A2 (en) 2005-06-06 2006-12-14 President And Fellows Of Harvard College Nanowire heterostructures
US20070072309A1 (en) * 2005-09-29 2007-03-29 General Electric Company Analytical compositions including nanometer-sized transducers, methods to make thereof, and devices therefrom
US20070082411A1 (en) * 2005-10-07 2007-04-12 Muys James J Detection and identification of biological materials using functionalized quantum dots
JP2009513798A (ja) * 2005-10-27 2009-04-02 クレムソン・ユニヴァーシティ 蛍光性の炭素ナノ粒子
WO2007049264A2 (en) * 2005-10-27 2007-05-03 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Assays using nanoparticles
US20090197291A1 (en) * 2005-10-27 2009-08-06 Yuri Volkov Assays Using Nanoparticles
US20080305047A1 (en) * 2005-12-19 2008-12-11 Raymo Francisco M Chemosensors Based on Quantum Dots and Oxazine Compounds
US20090220792A1 (en) * 2006-01-20 2009-09-03 Singapore Agency For Science, Tech And Research Synthesis of Alloyed Nanocrystals in Aqueous or Water-Soluble Solvents
US20100255462A1 (en) * 2006-01-27 2010-10-07 Konica Minolta Medical & Graphic, Inc. Fluorescent marker for living organism and fluorescent marking method for the same
CA2571904A1 (en) * 2006-02-15 2007-08-15 Fio Corporation System and method of detecting pathogens
US7858386B2 (en) * 2006-03-07 2010-12-28 The United States Of America As Represented By The Secretary Of The Navy Method of controlling quantum dot photoluminescence and other intrinsic properties through biological specificity
US8849087B2 (en) 2006-03-07 2014-09-30 Qd Vision, Inc. Compositions, optical component, system including an optical component, devices, and other products
CA2648702A1 (en) * 2006-04-04 2007-10-11 Arcxis Biotechnologies, Inc. Cooperative probes and methods of using them
US20070269852A1 (en) * 2006-05-18 2007-11-22 James Johan Muys Method and apparatus for detecting airborne pathogens using quantum dots
US9212056B2 (en) 2006-06-02 2015-12-15 Qd Vision, Inc. Nanoparticle including multi-functional ligand and method
WO2008008349A2 (en) * 2006-07-11 2008-01-17 Drexel University Methods of quantitatively assessing inflammation with biosensing nanoparticles
US20100120016A1 (en) * 2006-09-01 2010-05-13 Yanbin Li Methods and systems for detection of contaminants
US8058640B2 (en) 2006-09-11 2011-11-15 President And Fellows Of Harvard College Branched nanoscale wires
US20090280520A1 (en) * 2006-09-15 2009-11-12 Konica Minolta Medical & Graphic, Inc. Fluorescent semiconductor particles, method of manufacturing the same, biosubstance fluorescent labeling agent employing the same, and bioimaging method thereof
CA2858359C (en) * 2006-11-01 2018-04-03 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
EP2095100B1 (de) 2006-11-22 2016-09-21 President and Fellows of Harvard College Verfahren zum Betreiben eines Nanodraht-Feldeffekttransistorsensors
US9938641B2 (en) 2006-12-18 2018-04-10 Fluidigm Corporation Selection of aptamers based on geometry
CA2580589C (en) 2006-12-19 2016-08-09 Fio Corporation Microfluidic detection system
WO2008119184A1 (en) 2007-04-02 2008-10-09 Fio Corporation System and method of deconvolving multiplexed fluorescence spectral signals generated by quantum dot optical coding technology
WO2008124525A1 (en) * 2007-04-03 2008-10-16 Vanderbilt University Nanoparticles with molecular recognition elements
WO2008133945A1 (en) * 2007-04-25 2008-11-06 The Trustees Of The University Of Pennsylvania Low level fluorescence detection at the light microscopic level
KR100853086B1 (ko) * 2007-04-25 2008-08-19 삼성전자주식회사 나노결정-금속산화물 복합체 및 그의 제조방법
US7682789B2 (en) * 2007-05-04 2010-03-23 Ventana Medical Systems, Inc. Method for quantifying biomolecules conjugated to a nanoparticle
WO2008153744A2 (en) 2007-05-23 2008-12-18 Ventana Medical Systems, Inc. Polymeric carriers for immunohistochemistry and in situ hybridization
US20080317768A1 (en) * 2007-06-21 2008-12-25 Boeing Company Bioconjugated nanoparticles
WO2009000084A1 (en) 2007-06-22 2008-12-31 Fio Corporation Systems and methods for manufacturing quantum dot-doped polymer microbeads
CN101809433A (zh) 2007-07-09 2010-08-18 Fio公司 用于增强试样中靶分子荧光检测的***和方法
WO2009009630A1 (en) * 2007-07-11 2009-01-15 Clemson University Photoluminescent materials for multiphoton imaging
CN101809577B (zh) * 2007-07-23 2013-04-17 Fio公司 用于整理、存储、分析和支持访问与生物和环境检查对象有关的所收集和分析的数据的方法和***
CA2702367C (en) 2007-10-12 2012-08-21 Fio Corporation Flow focusing method and system for forming concentrated volumes of microbeads, and microbeads formed further thereto
US20100069550A1 (en) * 2008-03-17 2010-03-18 Washington, University Of Nanoparticle assemblies and methods for their preparation
EP2279268A4 (de) 2008-04-04 2011-12-07 Life Technologies Corp Scanning-system und verfahren zur bildgebung und sequenzierung
CA2720728C (en) 2008-06-05 2018-04-03 Ventana Medical Systems, Inc. Compositions comprising nanomaterials and method for using such compositions for histochemical processes
US8063131B2 (en) * 2008-06-18 2011-11-22 University Of Washington Nanoparticle-amphipol complexes for nucleic acid intracellular delivery and imaging
US9792809B2 (en) 2008-06-25 2017-10-17 Fio Corporation Bio-threat alert system
WO2010007803A1 (ja) * 2008-07-17 2010-01-21 コニカミノルタエムジー株式会社 ナノ粒子標識薬、及び該ナノ粒子標識薬を用いたシステム
GB0813273D0 (en) * 2008-07-19 2008-08-27 Nanoco Technologies Ltd Method for producing aqueous compatible nanoparticles
BRPI0917839A2 (pt) 2008-08-29 2015-11-24 Fio Corp dispositivo de teste de diagnóstico portátil de uso único, e um sistema associado e método para teste de amostras de teste ambientais e biológicas
US20100261212A1 (en) * 2009-01-09 2010-10-14 Chinmay Prakash Soman Kinetics of molecular recognition mediated nanoparticle self-assembly
EP2387721A4 (de) 2009-01-13 2014-05-14 Fio Corp Tragbare diagnosetestvorrichtung und verfahren zu deren verwendung mit einer elektronischen vorrichtung sowie testkartusche für schnelle diagnosetests
EP2389289A4 (de) 2009-01-23 2012-11-07 Univ Drexel Vorrichtung und verfahren für den nachweis von entzündungen anhand von quantenpunkten
CN102656233B (zh) 2009-05-01 2015-04-29 纳米***公司 用于纳米结构体分散的官能化基质
WO2011038228A1 (en) 2009-09-24 2011-03-31 President And Fellows Of Harvard College Bent nanowires and related probing of species
WO2011090445A1 (en) * 2010-01-22 2011-07-28 Huseyin Avni Oktem Method for detection of non-labeled pcr products on sandwich hybridization based array platforms
USPP22463P3 (en) * 2010-02-16 2012-01-17 Menachem Bornstein Gypsophila plant named ‘Pearl Blossom’
US20130101512A1 (en) 2010-03-12 2013-04-25 Chad A. Mirkin Crosslinked polynucleotide structure
US9121065B2 (en) 2010-08-09 2015-09-01 The Trustees Of The University Of Pennsylvania Nanoparticle-oligonucleotide hybrid structures and methods of use thereof
EP2658711B1 (de) * 2010-12-28 2019-06-12 Life Technologies Corporation Nanokristalle mit hohen extinktionskoeffizienten
US8679858B2 (en) * 2011-01-11 2014-03-25 The Board Of Trustees Of The Leland Stanford Junior University Lanthanide mass dots: nanoparticle isotope tags
US9448231B2 (en) * 2011-02-28 2016-09-20 Ventana Medical Systems, Inc. Application of quantum dots for nuclear staining
US9024526B1 (en) 2012-06-11 2015-05-05 Imaging Systems Technology, Inc. Detector element with antenna
US9139770B2 (en) 2012-06-22 2015-09-22 Nanosys, Inc. Silicone ligands for stabilizing quantum dot films
TWI596188B (zh) 2012-07-02 2017-08-21 奈米系統股份有限公司 高度發光奈米結構及其製造方法
FR3003353B1 (fr) * 2013-03-14 2015-03-06 Horiba Abx Sas Nouvelle methode de dosage en flux d'un objet d'interet
CA2905890C (en) 2013-03-14 2022-02-08 Nanosys, Inc. Method for solventless quantum dot exchange
US11015115B2 (en) 2015-12-31 2021-05-25 3M Innovative Properties Company Curable quantum dot compositions and articles
WO2017117160A1 (en) 2015-12-31 2017-07-06 3M Innovative Properties Company Article comprising particles with quantum dots
FR3058141A1 (fr) * 2016-11-03 2018-05-04 Universite Paris-Sud Nouveaux conjugues comprenant des nanocristaux semi-conducteurs et leur methode de preparation
CN111032678A (zh) 2017-06-26 2020-04-17 拜西克尔德有限公司 具有可检测部分的双环肽配体和其用途
US20200283482A1 (en) 2017-08-14 2020-09-10 Bicyclerd Limited Bicyclic peptide ligand prr-a conjugates and uses thereof
US20200291096A1 (en) 2017-08-14 2020-09-17 Bicyclerd Limited Bicyclic peptide ligand sting conjugates and uses thereof
PL240252B1 (pl) * 2017-10-10 2022-03-07 Univ Jagiellonski Nanorozmiarowy czujnik jonów rtęci i sposób jego otrzymywania oraz sposób wykrywania jonów Hg2+
GB201721265D0 (en) 2017-12-19 2018-01-31 Bicyclerd Ltd Bicyclic peptide ligands specific for EphA2
TWI825046B (zh) 2017-12-19 2023-12-11 英商拜西可泰克斯有限公司 Epha2特用之雙環胜肽配位基
GB201810316D0 (en) 2018-06-22 2018-08-08 Bicyclerd Ltd Peptide ligands for binding to EphA2
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
WO2020165600A1 (en) 2019-02-14 2020-08-20 Bicycletx Limited Bicyclic peptide ligand sting conjugates and uses thereof
CN110441526A (zh) * 2019-07-10 2019-11-12 浙江理工大学 一种基于蛋白质芯片技术鉴别羊毛纺织品文物样的方法
TW202110485A (zh) 2019-07-30 2021-03-16 英商拜西可泰克斯有限公司 異質雙環肽複合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4637988A (en) 1981-07-01 1987-01-20 Eastman Kodak Company Fluorescent labels for immunoassay
US4777128A (en) 1986-05-27 1988-10-11 Ethigen Corporation Fluorescence immunoassay involving energy transfer between two fluorophores
WO1990015666A1 (en) 1989-06-16 1990-12-27 Omni Quest Corporation Coated magnetic particles for use in separations
US5389377A (en) 1989-12-22 1995-02-14 Molecular Bioquest, Inc. Solid care therapeutic compositions and methods for making same
US5441746A (en) 1989-12-22 1995-08-15 Molecular Bioquest, Inc. Electromagnetic wave absorbing, surface modified magnetic particles for use in medical applications, and their method of production
EP0506880A1 (de) 1989-12-22 1992-10-07 Molecular Bioquest, Inc. Teilchen mit organo-metallischem überzug zur verwendung in abscheidungen
JP2970967B2 (ja) 1991-11-20 1999-11-02 浜松ホトニクス株式会社 蛍光性プローブ試薬を用いた細胞内イオン濃度測定法
WO1993010564A1 (en) * 1991-11-22 1993-05-27 The Regents Of The University Of California Semiconductor nanocrystals covalently bound to solid inorganic surfaces using self-assembled monolayers
US5505928A (en) * 1991-11-22 1996-04-09 The Regents Of University Of California Preparation of III-V semiconductor nanocrystals
US5248772A (en) 1992-01-29 1993-09-28 Coulter Corporation Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
JPH08500700A (ja) 1992-06-08 1996-01-23 バイオクエスト インコーポレイテッド 分離、磁気分子スイッチ、および医療用途の無機リポソームとして使用する粒径を制御した無機粒子の製造
US5674698A (en) 1992-09-14 1997-10-07 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
EP1818417B1 (de) * 1996-07-29 2014-02-12 Nanosphere, Inc. Nanopartikel mit angehängten Oligonukleotiden und ihre Verwendungen
JPH10226779A (ja) * 1996-12-12 1998-08-25 Mitsui Chem Inc 半導体超微粒子反応試剤
US5939021A (en) * 1997-01-23 1999-08-17 Hansen; W. Peter Homogeneous binding assay
AUPP004497A0 (en) * 1997-10-28 1997-11-20 University Of Melbourne, The Stabilized particles
US5990479A (en) * 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
GB9820271D0 (en) * 1998-09-17 1998-11-11 Simoco Int Ltd A method of and apparatus for monitoring the condition of batteries used by a mobile radio telecommunications fleet
DE69905832T2 (de) * 1998-09-18 2004-02-05 Massachusetts Institute Of Technology, Cambridge Biologische Verwendungen von halbleitenden Nanokristallen
JP4404489B2 (ja) * 1998-09-18 2010-01-27 マサチューセッツ インスティテュート オブ テクノロジー 水溶性蛍光半導体ナノ結晶
US6251303B1 (en) 1998-09-18 2001-06-26 Massachusetts Institute Of Technology Water-soluble fluorescent nanocrystals
US6426513B1 (en) 1998-09-18 2002-07-30 Massachusetts Institute Of Technology Water-soluble thiol-capped nanocrystals
WO2000017655A1 (en) * 1998-09-18 2000-03-30 Massachusetts Institute Of Technology Water-soluble fluorescent semiconductor nanocrystals
US6309701B1 (en) 1998-11-10 2001-10-30 Bio-Pixels Ltd. Fluorescent nanocrystal-labeled microspheres for fluorescence analyses
WO2000028598A1 (en) 1998-11-10 2000-05-18 Biocrystal Limited Methods for identification and verification
US6114038A (en) 1998-11-10 2000-09-05 Biocrystal Ltd. Functionalized nanocrystals and their use in detection systems

Also Published As

Publication number Publication date
DE69938353D1 (de) 2008-04-24
JP2002530630A (ja) 2002-09-17
US7192785B2 (en) 2007-03-20
JP4630459B2 (ja) 2011-02-09
WO2000029617A2 (en) 2000-05-25
EP1115888B1 (de) 2008-03-12
WO2000029617A9 (en) 2001-01-04
AU3468500A (en) 2000-06-05
US20030008414A1 (en) 2003-01-09
US6468808B1 (en) 2002-10-22
EP1115888A2 (de) 2001-07-18
WO2000029617A3 (en) 2000-11-09
CA2345376C (en) 2010-03-16
DE69938353T2 (de) 2009-03-05
CA2345376A1 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
ATE389030T1 (de) Wasserlösliche lumineszente quantum-dots sowie deren biokonjugate
ATE361977T1 (de) In vitro verfahren zur induzierung der regulierten pankreatische-hormon produktion in nicht-pankreatischen inselngeweben, damit verbundene pharmazeutische zusammenseztzungen
GT200100008A (es) Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
BR0215266A (pt) Preparação liofilizada compreendendo anticorpos contra o receptor de egf
SE9900519D0 (sv) A method for the preparation of UHMWPE doped with an antioxidant and an implant made thereof
ATE307593T1 (de) Mit einem tensid co-mikronisiertes progestin, pharmazeutische zusammensetzung dieses enthaltend,verfahren zu deren herstellung sowie verwendung
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
BR0115482A (pt) Composição de sacralose melhorada e processo para sua preparação
WO2002080754A3 (en) Methods for using annexin for detecting cell death in vivo and treating associated conditions
EP1169979A3 (de) Verfahren zum Befestigen eines Transplantats in einem Knochentunnel
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
WO2003094617A3 (en) Use of vegf for treating bone defects
ATE346610T1 (de) Zusammensetzung enthaltend, ein antigen, ein th-1 induzierendes adjuvans und eine im wasser schwer lösliche aminosäure, zur verwendung in der immunisierung
BR9913533A (pt) Processos para tratar hipertensão e composições para uso nos mesmos
DE69812365T2 (de) Enthaarungsmitteln, verfahren zur herstellung sowie ihre verwendung
PL346463A1 (en) Method of obtaining derivatives of resorcinol, method of obtaining novel derivatives of 2-oxazabicyclo[2.2.2.]-octan-5-one, method of obtaining novel derivatives of 1,3-cyclohezandione, method of obtaining novel derivatives of 2-cyclohexanone, novel derivatives of 2-oxazabicyclo[2.2.2.]-octan-5-one, novel derivatives of 1,3-cyclohexanodione, and novel derivatives of 2-cyclohexenonea
MXPA03011306A (es) Metodos para la preparacion y uso de 1a,24 (s) - hidroxivitamina d2.
WO2002003974A3 (en) Composition comprising folic acid and zinc for improving male fertility
EP1137041A4 (de) Elektronenstrahlgerät, verfahren zur herstellung eines ladungsunterdrückenden elements für die verwendung im genannten gerät und bilderzeugungsvorrichtung
BG100863A (en) Fibrin-specifil antibody and its use as an antithrombotic agent
DK1189627T3 (da) Sammensætninger indeholdende opløselige former af HLA-G til behandling af inflammatoriske patologiske tilstande i huden
DE50101479D1 (de) Fluoresceinisothiocyanat-(fitc)-sinistrin, seine herstellung und verwendung
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
ES2159201T3 (es) Articulo de vidrio coloreado tridimensional y metodo para su produccion.
DE69917440D1 (de) 5-imino-13-deoxy-antracyclin-derivate, ihre verwendung sowie verfahren zu deren herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties